Spanish Blood Cancer Library - What are the risks and benefits of Ibrutinib and Idelalisib? How do you manage the side effects of the new kinase inhibitors?

dbrock's picture

Submitted by dbrock on Wed, 11/08/2017 - 11:48

¿Cuáles son los riesgos y beneficios de ibrutinib y de idelalisib? ¿Cómo manejamos los efectos secundarios de los nuevos inhibidores de la tirosina cinasa?
Marco A. Ruiz, MD, GRACE Faculty

GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.

Video Language: 
Spanish

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation